Vir Biotechnology
VIR
Reported
Thursday, October 31
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.05 | -1.56 | -0.51 | -48.57% |
| Revenue | 5.51M | 2.38M | -3.13M | -56.81% |
WhatIF - Earnings
EPS Missed Expectations by -$0.51
Vir Biotechnology (VIR:NASDAQ) has never missed EPS by this much before
There’s a first time for everything